BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/14/2025 8:23:16 AM | Browse: 78 | Download: 369
 |
Received |
|
2025-06-03 01:26 |
 |
Peer-Review Started |
|
2025-06-12 09:14 |
 |
First Decision by Editorial Office Director |
|
2025-06-25 09:25 |
 |
Return for Revision |
|
2025-06-25 09:25 |
 |
Revised |
|
2025-07-09 04:49 |
 |
Publication Fee Transferred |
|
2025-07-17 08:11 |
 |
Second Decision by Editor |
|
2025-09-22 04:49 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-10-10 06:47 |
 |
Articles in Press |
|
2025-10-10 06:47 |
 |
Edit the Manuscript by Language Editor |
|
2025-10-18 23:00 |
 |
Typeset the Manuscript |
|
2025-11-07 06:13 |
 |
Publish the Manuscript Online |
|
2025-11-14 08:23 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cell Biology |
| Manuscript Type |
Basic Study |
| Article Title |
Optimizing adipose-derived stem cell therapy for diabetic foot ulcers
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jing Cao, Zi-Chao Liu, Wen-Qiang An, Sen Zhang, Xin Zhang, Li-Jie Li, Hai-Lian Ji, Xiao Long and Yue-Mei Yang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| The Zhongguancun National Independent Innovation Demonstration Zone Industrial Ecosystem Cultivation Project |
20220468089 |
|
| Corresponding Author |
Yue-Mei Yang, PhD, Department of Research and Development, Beijing AegleStem Therapeutics Co., Ltd, No. 1 Yuanping North Road, Daxing District, Beijing 102600, China. maeyang@aeglestem.com |
| Key Words |
Diabetic foot ulcer; Adipose-derived stem cell; Dose-response relationship; Phosphatidylinositol 3-kinase; Notch signaling pathway |
| Core Tip |
This study systematically evaluated the dose-response relationship, administration route, persistence, and mechanisms of adipose-derived mesenchymal stem cells (ADSCs) in diabetic foot ulcer healing. Subcutaneous injection of 5 × 10⁵ ADSCs showed optimal efficacy with prolonged retention. Mechanistically, ADSCs restore the PI3K-AKT-mTOR-HIF-1α-VEGF pathway to improve angiogenesis and inhibit the overactivated Notch signaling pathway to reduce inflammation and enhance collagen deposition. These results provide critical insights into the optimization of ADSC-based therapies and offer a promising approach for treating chronic diabetic wounds. |
| Publish Date |
2025-11-14 08:23 |
| Citation |
Cao J, Liu ZC, An WQ, Zhang S, Zhang X, Li LJ, Ji HL, Long X, Yang YM. Optimizing adipose-derived stem cell therapy for diabetic foot ulcers. World J Diabetes 2025; 16(11): 109859 |
| URL |
https://www.wjgnet.com/1948-9358/full/v16/i11/109859.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v16.i11.109859 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.